Investec
* AIRBUS-Q3 revs miss, Ebita small miss, keeps FY ebit f/cast...............-1%
* BANKIA-Q3 due 11:30
* BAYER-Q3 ebitda 6% beat, raises FY eps f/c, ebitda & rev f/c remain unch..+1%
* BOSS-plans to move away from luxury, focus on men’s premium mkt(HB).......+2%
* CAP GEM-Q3 sales in line, confirms FY guidance, wants bolt-on aqns in US..+1%
* CHR HANSEN-FY touch blw our ests, div better (70c vs 69c), comment follows..-1%
* EDF-spec of Polish sales soon; confident comments on French nuclear safety..+1%
* EDP-sells €100m of tariff deficit, analyst says small incremental +ive....+1%
* FERROVIAL-Q3 due after close
* HAVAS-Q3 org rev +2%, implies Q3 slowdown as 9m is 2.7%...................-1%
* HEINEKEN-Q3 organic beer vols +2%(est +1.4%), mkt prob expected a beat....+1%
* IBERDROLA-9m no’s in line to a touch ahead, comment to follow.............U/C
* INGENICO-due after close
* KERING-Q3 org gth +10.5% (+7%),big beat at Gucci, highly confident for FY..+3%
* KLEPIERRE-due after close
* KRONES-Q3 revs 2% ahead, confirms FY, gives outlook to 2020...............+2%
* LOGITECH-Q2 rev 7% beat, eps 35c vs est 25c, keeps outlook................+5%
* NOKIA-Juniper +7% after hours on Q3 beat/Q4 guidance......................+1%
* NORDEA-Q3 numbers mixed, CET1 17.9% vs est 17.4%, strong into no’s........-1%
* NOVOZYMES-Q3 miss, guides FY lower, comment to follow.....................-3%
* PEUGEOT-Q3 rev small miss (1.5%), keeps rev gwth targets...................-1%
* RED ELEC-Q3 net matches ests..............................................U/C
* RENAULT-Q3 rev 1% ahead, confirms FY guidance.............................U/C
* SAIPEM-Q3 beat, confirms 2016,2017 guidance mixed,mkt may have priced in..+1%
* SANTANDER-Q3 net 10% ahead of cons, CET1 in line,‘in line to meet goals’..+3%
* SEB SA-Q3 org sales 6%,looks like a raise to org sales & op profit ests..+3%
* SKF-due midday
* TEF DEUTSCH-Q3 oibda 1% ahead of cons, reits FY f/casts...................U/C
* TELENOR-Q3 rev in line, net miss(impairments), ebitda beat, o/look unch...+1%
* UNIBAIL-Q3 gross retail inc +6.7%, reits FY eps guidance..................U/C
* WIRECARD-Q3 in line, raised guidance on 4th Oct...........................U/C
* VINCI-Q3 rev 2% light, confirms FY outlook................................-1%
Other
* FORTUM - reit SELL, TP €11 from €10. Note published.
* ANTO'S-Update. Prod. at lower end, lowers FY17 fcast.......................-2%
* ASTRAZENECA-Positive results from Lynparza Phase 3 trial.................unch
* BUZL-Q3. #'s in line, FX positve.B/S remains strong. Weak into stmnt....+1-2%
* CYBG-Makes preliminary approach for RBS W&G unit..........................-3%
* GENEL-Update. Prod & guid small miss. Lowers FY17 guidance. Weak into stmnt...-5%
* GLAXO-Q3 due midday
* IMAG.TECH-Apple Q1 gross margin a miss, -2.5% after hrs...................-2%
* LLOYDS-Q3.PBT 1% miss. CET1 ratio better. Reaffirms Q2 expectations.......-2%
* MEGGITT-Wins $48m Chinese helicopter contract with Hangxin...............unch
* RBS-CYBG makes preliminary approach for RBS W&G unit......................+1%
* REDDE-Update.+ve momentum continues. Profit ahead of expectations.........+2%
* SIERRA RUTILE-Merger update. Extends discussion until 4th Nov. In line....unch
* VODAFONE-Fined £4.6m for breaching OFCOM billing rules....................-1%
Credit Suisse
Abertis M/P Revs €3.61bn vs cons 3.605bn, EBITDA €2.41bn vs cons €2.4bn
Aena -0.5% Q3 revenues 1.4% light, Q3 EBITDA 1.7% ahead
Antofagasta -4-5% Negative on Q4/FY16 & 17 Guidance
Airbus -1% Revenues 1% light, FCF 17% worse
Acerinox +1-2% EBITDA slightly ahead, guidance fine
Bayer R 3Q EBITDA ex items from cont. ops EU2.68B est EU2.53B
Bunzl M/P Trading update inline with market expectations
Capgemini -2% 3Q sales fall 0.6%, confirms 2016 outlook
Chr Hansen +1-2% EBIT inline, net slightly better, confirm FY guidance
Cramo -1-2% Q3 sales €184.8m, cons 186.4m, confirms FY guidance
Fred Olsen M/P Q3 Revs6% ahead, EBITDA $119m, cons 121m
Genel -3-5% 2016 revs now seen at bottom end of guidance
Gjensidige -1-2% 3Q pretax NOK1.52b cons NOK1.66b
Huhtamaki -1-2% Sales €719m vs cons €746m
Inmarsat UNCH CS REITERATE OUTPERFORM (TP 940p from 1060p)
Heineken +1% Organic consolidated beer volume beats estimates
Iberdrola +1-2% 9M ADJ. NET EU2.04B, est EU2B
Kering +5% Good numbers - Gucci LFL sales +17% (est +10)
Logitech +5-8% Q2 revenues 6% ahead, Non-GAAP EBIT 28% ahead
Lloyds -0.5% Bottom line a 3% miss, CET ratio 13.4% vs 13.3%
Meggitt +0.5% Awarded $48m contract to supply Health/Usage Monitoring Sys
Miners -1-2% Copper -0.40%, Brent -1.25%, Iron Ore +0.45%, China -0.24%
O2D +1% 3Q revs 1.88bn vs 1.82bn cons, reiterates forecast
Oils -1% API data announced a Crude build of 4.75M barrels
Nordea +1-2% Bottom line a 10% beat, CET1 at 17.9%, 50bps ahead of cons
Novozymes -3-5% Org growth disappointing, guidance adjusted to lower end
Nostrum +1% Production at 38.9 kb/d, cons 40 kb/d, guidance maintained
Peugeot +1% Sales broadly inline, lifts Europe
Red Elec M/P 3Q Net EU147.8m looks inline with consensus
Renault -1% Revenues 1.5% beat, confirmed FY forecasts
Saipem -3-5% Q3 numbers a beat, guidance weak and debt higher
Santander +1-2% CET1 up ~10bps from 10.36% to 10.47%, net income a 9% beat
SEB +1-2% Q3 rev E1.2b cons E1.18b, raises FY targets
Telenor +1% Revs in-line, EBITDA a beat by 3%
Unibail -1% 9m results inline, turnover up 5% YoY, reiterates forecast
Vinci M/P Q3 revs E10b (cons E10.2b) and confirms FY outlook
Wirecard M/P Q3 sales €268m vs cons €265m, EBITDA slightly ahead
XXL ASA -2% Q3 revs NOK2.08bn vs cons 2.19bn, keep FY guidance
RBC
*ABERTIS: +1% Q3 net income in line, EBITDA small beat.
*AIRBUS: -2% Q3 profit falls 21% on A350 costs, rev miss, FY confirmed.
*ANTO: +1% Q3 update mixed, copper prod in line, 17 guidance in focus.
*BAYER: +1% Q3 core EPS beat, raises FY Core EPS goal.
*BMW/DAI: -1% read from GREAT WALL MOTORS (-10.5%) on weak Q3 numbers.
*BOSS: +1% CEO suggests movement away from luxury towards premium segment,
*B. POPULAR: -2% Il CONFIDENCIAL: unlikely to meet Q3 estimates.
*BUNZL: -3% Q3 organic growth flat v +1% expect.,
*CAPGEMINI: 0% Q3 sales -0.6%, confirming FY guidance.
*DLG: -3% weak read through from APPLE (-3%) after hours.
*GENEL ENERGY: -3% FY prod guided down on weak production.
*HEINEKEN: +1% Q3 slight beat on volumes, +2% v +1.6% consensus, FY expectation reit.
*IBEDROLA: 0% Q3 EBITDA and net income in line, FY financial targets confirmed.
*KERING: +3% best quarter results in 3 years, Gucci +17% & Saint Laurent +34%.
*KONECRANES: +1% Q3 order intake weak, net sales and profit ahead.
*LLOYDS: -1% Q3 mixed, capital ratio increased to 13.4%, provisions 15% worse.
*LOGITECH: +3% Q2 rev beat, FY guidance confirmed.
*METRO BANK: -2% Q3 numbers in line, achieved first quarterly profit ever, downgraded.
*PEUGEOT: 0% Q3 rev miss on Chinese-European weakness, FY guidance confirmed.
*RENAULT: -1% Q3 rev in line, FY guidance confirmed.
*RED ELECTRICA: -1% Q3 results in line, EBIT & net profit tad light.
*NORDEA: +2% Q3 pre-tax profit 7% above consensus, NII slight miss.
*NOVOZYMES: -4% Q3 revs 7% miss, gross profit light, downgrades growth targets.
*SANTANDER: +2% Q3 beat, NII ahead, revenues better.
*STOREBRAND: +2% Q3 mixed, improved solvency, operating profit miss, net profit beat.
*TELEFONICA: +1% Q3 rev & EBITDA beat, good subs growth & FY guidance reiterated.
*TELENOR: +2% Q3 revs in line, EBITDA beat, FY guidance reiterated.
*VINCI: 0% Q3 revs light, but confirms FY outlook.
Shore Cap
LLOYDS-Q3 ptp 1.91b(Est2.04b).£1b PPI charge.740m pension deficit in Q3.....-3%
BUNZL-Q3 grp rev +7%.Says total performance is consistent with views.......UNCH
VODAFONE-OFCOM fines Vodafone 4.6m for failing customers....................-1%
MEGGITT-Sensing system gets $48m contract..................................UNCH
REDDE-Says trading profit is ahead of forecasts as sales gain...............+3%
CENTAUR MEDIA-Says expects to meet market estimates for year...............UNCH
PEARSON-said to be in talks to sell TutorVista..............................+1%
METRO BK-deposits +66% record increase in new accounts and swings into pft..+1%
RBS- CYBG confirms in discussion to buy Williams and Glyn...................+1%
ASTRAZEN-Phase3 ovarian cancer drugs shows improvement in survival rates...UNCH
Julius Baer
SMI -0.2%
BALN +0.9%
LOGN +5.8%
Tradegate
BAYN +1.2%
TKA -0.7%
Norma -2.6%
Krones +2%
WDI +2%
O2D +1.4%
AIR -0.6%
Santander +2.1%
CAP +0.7%
BOSS +0.2%
NZY -1.6%
Nordea +1.5%
Novo +0.7%
SBRY +2.4%
Uniper -2%
MainFirst
*BOSS-CEO wants to abandon luxury segment-Focus CMD 16th Nov........U/C
*AIRBUS-Rev 13.95b(14.7),Ebit 731m(735),Supply chain difficult......-2%
*NORDEA-NII 1.18B(1.19),CET1 17.9%(17.4),NI 888M(824.9).............+2%
*BSCH-Net 1.7b(1.54),CET1 Fully Loaded 10.47%,NII 7.8b..............+1%
*TELENOR-Rev 32.8b(32.9),Ebitda 12.5b(12),Loss 4.82b(+122.7)........+2%
*BIC-Q3 Sales 559.6m(561),Q3 EPS 1.57,Net 73.6m,Confirms FY o/l.....-2%
*RENAULT-Q3 Rev €10.55b(10.41),Confirms FY forecasts...............-1%
*KERING-Sales €3.18b(3.09),OG 10.5%(10),Gucci 17%(10),Puma 10.8%....+3%
*SEB-Rev 1.2b(1.18),ORG 6.5%,Raises FY targets......................+2%
*VINCI-Rev 10b(10.2),Confirms FY outlook, Order book s/decline.......+0.5%
*SAIPEM-Ebitda 328m(306),OP 155m(137),NI 60m(66),o/l confirmed......+2%
*LOGITECH-Sales $564m(526.2),EPS 35c(25),Ebit 53.4m(38).............+5%
*IPSEN-Q3 Sales 390.6m(400),Guidance raised for 2016................+1%
*HUHTAMAKI-Net Sales 719m(746.3),Ebit 67m(73.4),Capex revised.......-2%
*CAP GEM-Sales 3.02b(3.05),wants 2 make bolt on acq’s, Reit FY.......-1%
*BAYER-Ebitda 2.68b(2.53),Sales 11.62b(11.3),EPS 1.73(1.65).........+1%
*PEUGEOT-Q3 Rev 11.4b(11.56),Reits 2015-18 Rev.Grth target..........-1%
*KRONES-Rev 819.8m(802.8),EBT 56.3m(55.9),Confirms 2016 o/l.........+1%
*SHW-Rev 96.9m(104),Ebitda 10.7m(11),Net 3.4m(3.3),FY low end.......-1%
*O2D-Rev 1.88b(1.88),Net -105m(-90),Reits outlook for 2016..........+0.5%
*HEINEKEN-Organic Beer Vols 2%(1.4),Cons Beer Vols 54MHL(53.5)......+0.5%
*WIRECARD-Q3 Ebitda 81.4m(81),Sales 268m(267.5),+ve on Q4...........+2.5%
*KESKO-Sales 2.79b(2.81),Ebit 98.2m(91),EPS 73c(65),FY OK...........+1%
*UNIBAIL-9M Rev 1.5b,Gross Rental Inc 1.32b,sells 2 buildings.......U/C
Macquarie
* AstraZeneca AZN - Positive results in AstraZeneca Lynparza trial (Ovarian Cancer drug) +1%
*Atlantis Resources ARL- MeyGen project on track to have all turbines installed & on track by end of year. Unch
*Bunzl BNZL- trading inline, Q3 rev +7%, plans further acquisitions & funding headroom available; +1%
*CYBG- Confirms Press Spec that it is in preliminary decisions with RBS in relation to Williams & Glyn acquisition. (£1.5bn has been price mentioned) -2%
*Genel GENL- Guiding Production towards lower end of Guidance Range (c10% Downgrade). Capital expenditure also being lowered. Already factored in? -5%
*Lloyds LLOY- Underlying pretax profit GBP1.91b; est. GBP2.04b. Statutory pretax GBP811m vs GBP958m. Revenue GBP4.275b vs GBP4.237b, CET1 ratio 13.4% vs 2Q’s 13%. -1%
*Metro Bank MTRO- Q3 Update- Loans & Deposits up 12% in the quarter, customer accounts increased 68k to 848k. Total Rev up 15%. +1%
*Nostrum Oil NOG- Maintained production above 44,000 boepd, Full Year guidance remains at 40,000 boepd. Continues to reduce costs. +2%
*RBS- CYBG announces they have made an approach for the W&G branch network. Unch
Commerzbank
DAX Future -0.02% at 10740
AIR -0.7% Q3 in line, guidance confirmed, Q4 needs to deliver
BAYN +0.4% Strong margin development all over, modest increase in adj. EPS guid
BOSS +0.3% To pivot away from luxury market
CON –1.1% MS cuts to Equalweight (Overweight) – PT €185 (200)
DBK -0.7% Said to weigh alternatives to cash bonus payments
DLG –2.4% Apple -3% after hours, guidance mildly supportive
KRN +2.2% Solid Q3 with strong orders, new medium term targets focus on growth
O2D +0.7% Q3 above due to mobile service revenues
PUM +0.1% Q3 sales slightly above
SW1 –1.6% Misses on Q3, guidance challenging
VOW3 +0.1% Receives final approval for US civil settlement over $14.7bn
WDI +1.8% Delivery of anticipated strength in Q3
JefferiesKERING: Q3
#s GOOD, impressive performance from premium brands, we reit BUY
TELENOR: Q3
#s IN LINE/BETTER and also reit guidance, stock had good run tho .. called -2%
RENAULT: Q3 revenues BEAT ~1%, but c/call didn't go well, we reit U/P...... called -2%
AIRBUS: Q3
#s MISS rev/EBIT, reit FCF + confirms o/lk, supply chain issue.. called -1%
NORDEA: Q3
#s IN LINE, but NII S/LITE sees improved NI margin in Q4 ... called +2%
O2 DEUTSCHLAND: Mobile service revenues -1.8% vs -2% cons ... called +1%
SANTANDER: Q3 NII at EUR 7.79bn, 1% above exp, fees at 2.597bn 1% above ... called +2%
IPSEN: RAISES guidance for Specialty Care sales to above 15% growth, we reit BUY ... called +1%